Fungicidal 2-(bicyclic aryloxy)carboxamides 机翻标题: 暂无翻译,请尝试点击翻译按钮。

公开号/公开日
WO2011087837 A2 2011-07-21 [WO201187837]WO2011087837 A9 2011-09-09 [WO201187837]WO2011087837 A3 2012-01-12 [WO201187837] / 2011-07-212011-09-092012-01-12
申请号/申请日
2010WO-US61765 / 2010-12-22
发明人
CREWS JR ALVIN DONALD;DING AMY X;TSENG CHI-PING;
申请人
DU PONT DE NEMOURS;
主分类号
IPC分类号
A01N-037/34A01N-039/04C07C-215/20C07C-235/08C07C-255/53
摘要
(WO201187837) Disclosed are compounds of Formula 1, N-oxides, and salts thereof (Formula 1) wherein Q is O or S; Z1 and Z2 are each independently CR9 or N; and R1, R2 ,R3 ,R4 ,R5 ,R6 ,R7 ,R8 and R9 are as defined in the disclosure.  Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
代理机构
;
优先权号
2009US-61289000 2009-12-22
主权利要求
(WO201187837) CLAIMS is claimed is: A compound selected from Formula 1, N-oxides and salts thereof,  wherein Q is O or S; Z1and Z2are each independently CR9or Ν; R1is Ci-C2alky!>C2-C4alkenyl, C2-C4alkynyl, Ci-C4haloalkyl, C2-C4 haloalkenyl, C2-C4haloalkynyl, C3-C4halocycloalkyl, C4-C5 cycloalkylalkyl, C2-C4alkoxyalkyl, C2-C4alkylthioalkyl, C2-C4alkylsulfinylalkyl, C2-C4alkylsulfonylalkyl, C2-C4cyanoalkyl, C2-C6alkylcarbonyl, C2-C6alkoxycarbonyl, C1-C4alkoxy or C1-C4haloalkoxy; R2is hydrogen, Ci-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2-C6haloalkynyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C2- Cg cyanoalkyl, C2-Cg alkoxyalkyl, C3~Cg alkoxyalkoxyalkyl or benzyloxy(C2- C3alkyl); R3is C1-Cg alkyl, C2-Cg alkenyl or C2-Cg alkynyl, each optionally substituted with substituents independently selected from halogen, hydroxy, cyano, nitro, amino, C(=O)OH, C(=O)NH2, C(=O)R10, C(=O)OR11, C(=O)NR12R13, OC(=O)R10, SC(=O)R10, OC(=O)ORN, OC(=O)NR12R13, N(R12)C(=O)R10, NCR!^CC^OR!^ NCR!^CC^ R^R13, OSO2R14, OSO2NR12R13, NR12SO2R14, NR12SO2NR12R13, OR15, R12R13, S(0)nR14, S02NR12R13, P(=O)(R17)2, OP(=O)(R17)2, SI(R18)3, C(= NR12R13)R19, N=CR19NR12R13, CH=NR21and -CHfO(CH2)]; or R3is NR12R13; or R3is a 3-, 4-, 5- or 6-membered saturated carbocyclic ring optionally substituted with up to 5 substituents independently selected from R20; or a 3-, 4-, 5- or 6- membered heterocyclic ring containing ring members selected from carbon atoms and up to 4 heteroatoms selected from up to 2 oxygen, up to 2 sulfur and up to 3 nitrogen atoms, wherein up to 3 carbon atom ring members are independently selected from C(=O) and C(=S), and the sulfur atom ring members are independently selected from S(=O)p(=NR16)q, the heterocyclic ring optionally substituted with up to 5 substituents independently selected from R20on carbon atom ring members and R20aon nitrogen atom ring members; R4, R5, R7and R8are each independently selected from hydrogen, halogen, cyano, amino, nitro, -CHO, C1-C^ alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C^ haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C^Cg alkylcycloalkyl, C ~Cg cycloalkylalkyl, C3-C6 cycloalkenyl, C2-C6 alkoxyalkyl, C2-C6 alky lthio alkyl, C2-C6 alkylcarbonyl, C2-C6 haloalkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl, C2-C6 cyanoalkyl, C1-C^ alkoxy, C1-C^ haloalkoxy, C2-C6 alkoxyalkoxy, C1-Cg alkylthio, C1-Cg haloalkylthio, C1-Cg alkylsulfinyl, C1-C^ haloalkylsulfinyl, C1-C^ alkylsulfonyl, C1-C^ haloalkylsulfonyl, C3-C9 trialkylsilyl, C1-Cg alkylamino, C2-C6 dialkylamino, C2-C6 haloalkylamino, C2-C6 halodialkylamino and C2-C6 alkylcarbonylamino ; R6is halogen, cyano, amino, nitro, -CHO, C1-C6alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-Cg haloalkyl, C2-C6 haloalkenyl, C -Ce haloalkynyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C4-Cg alkylcycloalkyl, C ~Cg cycloalkylalkyl, C3-C6cycloalkenyl, C2-C6 alkoxyalkyl, C2-C6 alkylthioalkyl, C2-C6 alkylcarbonyl, C2-C6 haloalkylcarbonyl, Cj-Ce alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3~Cg dialkylaminocarbonyl, C2-C6 cyanoalkyl, C1-Cg alkoxy, C1-Cg haloalkoxy, Cj-Ce alkoxyalkoxy, C1-Cg alkylthio, C1-Cg haloalkylthio, C1-C6alkylsulfinyl, C1-C6haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-Cg haloalkylsulfonyl, C1-Cg alkylamino, C2-C6 dialkylamino, C2-C6 haloalkylamino, C2-C6 halodialkylamino or C2-C6 alkylcarbonylamino; each R9is independently selected from hydrogen, halogen, cyano, amino, nitro, -CHO, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, Ci-C6haloalkyl, C2-C6haloalkenyl, C2-C6 haloalkynyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C4- Cg alkylcycloalkyl, C ~Cg cycloalkylalkyl, C3-C6cycloalkenyl, C2-C6 alkoxyalkyl, C2-C6 alkylthioalkyl, C2-Cg alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3~Cg dialkylaminocarbonyl, C2-C6 cyanoalkyl, C1-Cg alkoxy, C1-Cg haloalkoxy, C2-C6 alkoxyalkoxy, C1-Cg alkylthio, C1-Cg haloalkylthio, C1-Cg alkylsulfinyl, C1-Cg haloalkylsulfinyl, C1-Cg alkylsulfonyl, C1-Cg haloalkylsulfonyl, C3-C9 trialkylsilyl, C1-Cg alkylamino, C2-C6 dialkylamino, C2-C6 haloalkylamino, C -Ce halodialkylamino and C2- Cg alkylcarbonylamino; each R10is independently selected from hydrogen, C1-C6alkyl, C1-C6haloalkyl, C3- Cg cycloalkyl and C3-C6halocycloalkyl; each R11is independently selected from C1-C^ alkyl, C1-C^ haloalkyl, C3-C6cycloalkyl and C3-C6halocycloalkyl; each R12is independently selected from hydrogen, CHO, C1-C^ alkyl, C1-C^ haloalkyl and C2-C6 alkylcarbonyl; each R13is independently selected from CHO, C1-C^ alkyl, C1-C^ haloalkyl and C2- Cg alkylcarbonyl; each R14is independently C1-Cg alkyl or C1-Cg haloalkyl; each R15is independently selected from CHO, C1-C^ alkyl, C1-C^ haloalkyl and C2- Cg alkoxyalkyl; each R16and R19is independently hydrogen or C1-C3 alkyl; each R17is independently C1-C^ alkyl or C1-C^ alkoxy; each R18is independently C1-C^ alkyl; each R20is independently selected from halogen, cyano, C1-C^ alkyl, C1-C^ haloalkyl, C2-C6 alkylcarbonyl, C1-Cg alkoxy, C1-Cg haloalkoxy and C1-Cg alkylthio; each R20ais independently selected from cyano, C1-Cg alkyl, C1-Cg haloalkyl and C2-C6 alkylcarbonyl; each R21is a 5-membered unsaturated heterocyclic ring containing 2-4 carbon atoms and 1-3 nitrogen atoms as ring members, wherein the heterocyclic ring is optionally substituted with up to 2 substituents independently selected from R20on carbon atom ring members and R20aon nitrogen atom ring members; each n is independently 0, 1 or 2; and p and q are independently 0, 1 or 2 in each instance of S(=O)p(=NR16)q, provided that the sum of p and q is 0, 1 or 2; provided that the compound of Formula 1 is other than 2-[(7-methoxy-2-naphthalenyl)oxy]-N-(2- propen- 1 -yl)-propanamide. 2. A compound of Claim 1 wherein: Q is O; Z2is CR9; R1is C1-C2alk lorC1-C4alkoxy; R2is hydrogen; R3is C1-Cg alkyl or C2~Cg alkynyl, each optionally substituted with up to 3 substituents independently selected from cyano, hydroxy, OR15and CHO; R4, R5, R7, R8and R9are each independently selected from hydrogen and C1-C^ alkyl; and R6is halogen, C1-C2 alkoxy, C1-C2 haloalkoxy or C2-C3 alkynyl. 3. A compound of Claim 2 wherein: Z1is CR9; R1is methyl, ethyl or methoxy; R3is C1-Cg alkyl optionally substituted with cyano or OR15; R4, R5, R7, R8and R9are each independently selected from hydrogen, methyl and ethyl; and R6is halogen, C1-C2 alkoxy or C2-C3 alkynyl. 4. A compound of Claim 2 wherein: Z1is CR9; R1is methyl, ethyl or methoxy; R3is C3-C8alkynyl; R4, R5, R7, R8and R9are each independently selected from hydrogen, methyl and ethyl; and R6is halogen, C1-C2 alkoxy or C2-C3 alkynyl. 5. A compound of Claim 3 wherein: R3is C(CH3)2CN, C(CH3)2CH2OCH3, C(CH3)2CH20CH2OCH3 or C(CH3)3.; and R6is bromo, methoxy, ethoxy, C≡CH or C≡CCH3.. 6. A compound of Claim 4 wherein: R3is C(CH3)2C≡CH or C(CH3)2C≡CCH3; and R6is bromo, methoxy, ethoxy, C≡CH or C≡CCH3.. 7. The compound of Claim 1 which is selected from the group: 2-[(7-bromo-2-naphthalenyl)oxy]-N-(2-methoxy-l,l-dimethylethyl)butanamide; 2-[(7-bromo-2-naphthalenyl)oxy]-N-[2-(methoxymethoxy)-l,l- dimethylethyl]butanamide; 2-[(6-iodo-3-quinolinyl)oxy]-N-(2-methoxy-l,l-dimethylethyl)butanamide; N-(l,l-dimethylethyl)-2-[(6-iodo-3-quinolinyl)oxy]butanamide; N-(l,l-dimethylethyl)-2-[(7-methoxy-2-naphthalenyl)oxy]butanamide; 2-[(7-bromo-2-naphthalenyl)oxy]-N-(l,l-dimethylethyl)butanamide; 2- [(7-bromo-2-naphthalenyl)oxy] -N- [2- [ [(dimethylamino)methylene] amino] - 1,1- dimethylethyl]butanamide; 2-[(7-bromo-2-naphthalenyl)oxy]-N-(2-methoxy-l,l-dimethylethyl)propanamide; 2-[(7-bromo-2-naphthalenyl)oxy]-N-(2-fluoro-l,l-dimethylethyl)butanamide; 2-[(7-ethynyl-2-naphthalenyl)oxy]-N-(2-methoxy-l,l-dimethylethyl)butanamide; 2-[(7-ethynyl-2-naphthalenyl)oxy]-2-methoxy-N-(2-methoxy-l,l- dimethylethyl)acetamide; 2-[(7-ethynyl-2-naphthalenyl)oxy]-N-[2-(methoxymethoxy)-l,l- dimethylethyl]butanamide; N-( 1 -cyano- 1 -methylethyl)-2-[(7-ethynyl-2-naphtlialenyl)oxy]butanamide; N-( 1 , 1 -dimethyl-2-butyn- 1 -yl)-2-[(7-ethynyl-2-naphthalenyl)oxy]butanamide; N-(l,l-dimethylethyl)-2-[(7-ethynyl-2-naphtlialenyl)oxy]butanamide; 2-[(7-bromo-2-naphthalenyl)oxy]-2-metlioxy-N-(2-metlioxy-l,l- dimethylethyl)acetamide; N-(2-methoxy- 1 , 1 -dimethylethyl)-2-[[7-( 1 -propyn- 1 -yl)-2- naphthalenyl]oxy]butanamide; 2-methoxy-N-(2-methoxy- 1 , 1 -dimethylethyl)-2-[[7-( 1 -propyn- 1 -yl)-2- naphthalenyl]oxy]acetamide; N-(l,l-dimethylethyl)-2-[(7-ethoxy-2-naplitlialenyl)oxy]butanamide; N-( 1 , 1 -dimethyl-2 -propyn- 1 -yl)-2-[(7-ethoxy-2-naphthalenyl)oxy]butanamide; and N-(l,l-dimethyl-2-propyn-l-yl)-2-[(7-ethoxy-2-naphthalenyl)oxy]-2- methoxyacetamide. 8. A fungicidal composition comprising (a) a compound of Claim 1; and (b) at least one other fungicide. 9. A fungicidal composition comprising (a) a compound of Claim 1; and (b) at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. 10. A method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof, or to the plant seed, a fungicidally effective amount of a compound of Claim 1.
法律状态
(WO201187837) LEGAL DETAILS FOR WO2011087837  Actual or expected expiration date=2013-06-22    Legal state=DEAD    Status=LAPSED     Event publication date=2010-12-22  Event code=WO/APP  Event indicator=Pos  Event type=Examination events  Application details  Application country=WO WOUS2010061765  Application date=2010-12-22  Standardized application number=2010WO-US61765     Event publication date=2011-07-21  Event code=WO/A2  Event type=Examination events  International application published with declaration under Article 17 (2) (a)  Publication country=WO  Publication number=WO2011087837  Publication stage Code=A2  Publication date=2011-07-21  Standardized publication number=WO201187837     Event publication date=2011-09-09  Event code=WO/A9  Event indicator=Pos  Event type=Examination events  International application or ISR republished with corrections, alterations  Publication country=WO  Publication number=WO2011087837  Publication stage Code=A9  Publication date=2011-09-09  Standardized publication number=WO201187837     Event publication date=2012-01-12  Event code=WO/A3  Event indicator=Pos  Event type=Examination events  Later publication of ISR with revised front page  Publication country=WO  Publication number=WO2011087837  Publication stage Code=A3  Publication date=2012-01-12  Standardized publication number=WO201187837     Event publication date=2013-06-22  Event code=WO/EETL  Event type=Event indicating Not In Force  PCT Application validity period expired. LEGAL DETAILS FOR DESIGNATED STATE AU2010341457  Actual or expected expiration date=2015-07-16    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=AU Corresponding appl: AU2010341457  Application date in the designated or member state=2010-12-22   Application number in the designated or member state=2010AU-0341457 Corresponding cc:  Designated or member state=AU Corresponding pat: AU2010341457  Publication stage code in the designated or member state=A1  Publication date in the designated or member state=2012-05-24   Publication number in the designated or member state=AU2010341457    Event publication date=2012-05-02  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=AU     Event publication date=2012-05-24  Event code=WO/ENP  Event type=Entry into national phase  Entry into the national phase in: Corresponding cc:  Designated or member state=AU     Event publication date=2015-07-16  Event code=AU/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=AU  LEGAL DETAILS FOR DESIGNATED STATE BR112012015297  Actual or expected expiration date=2017-07-11    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=BR Corresponding appl: BR112012015297  Application date in the designated or member state=2010-12-22   Application number in the designated or member state=2012BR-0015297 Corresponding cc:  Designated or member state=BR Corresponding pat: BR112012015297  Publication stage code in the designated or member state=A1  Publication date in the designated or member state=2013-10-01   Publication number in the designated or member state=BR112012015297    Event publication date=2013-10-01  Event code=WO/REG  Event code=BR/B01A  Event type=Examination events  Reference to a national code Pct publication - request for entry into the national phase Comunicacao da publicacao internacional pct. apresentacao de peticao de requerimento de entrada na fase nacional Corresponding cc:  Designated or member state=BR     Event publication date=2017-06-27  Event code=WO/ENP  Event type=Entry into national phase  Entry into the national phase in: Corresponding cc:  Designated or member state=BR   Effective date of the event=2012-06-21     Event publication date=2017-10-31  Event code=BR/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=BR  LEGAL DETAILS FOR DESIGNATED STATE CN102844296  Actual or expected expiration date=2013-08-14    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=CN Corresponding appl: CN201080059106  Application date in the designated or member state=2010-12-22   Application number in the designated or member state=2010CN-80059106 Corresponding cc:  Designated or member state=CN Corresponding pat: CN102844296  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2012-12-26   Publication number in the designated or member state=CN102844296    Event publication date=2013-08-14  Event code=CN/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=CN  LEGAL DETAILS FOR DESIGNATED STATE DE  Actual or expected expiration date=2012-06-22    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=DE     Event publication date=2012-06-22  Event code=WO/NENP  Event type=Event indicating Not In Force  Non-entry into the national phase in: Corresponding cc:  Designated or member state=DE  LEGAL DETAILS FOR DESIGNATED STATE EP2516385  Actual or expected expiration date=2012-11-06    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=EP Corresponding appl: EP10798443  Application date in the designated or member state=2010-12-22   Application number in the designated or member state=2010EP-0798443 Corresponding cc:  Designated or member state=EP Corresponding pat: EP2516385  Publication stage code in the designated or member state=A2  Publication date in the designated or member state=2012-10-31   Publication number in the designated or member state=EP2516385    Event publication date=2011-09-07  Event code=WO/121  Event type=Designated states  EP: The EPO has been informed by wipo that ep was designated in this application Corresponding cc:  Designated or member state=EP     Event publication date=2012-12-12  Event code=EP/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=EP  LEGAL DETAILS FOR DESIGNATED STATE IN4138/DELNP/2012  Actual or expected expiration date=2030-12-22    Legal state=ALIVE    Status=PENDING   Corresponding cc:  Designated or member state=IN Corresponding appl: IN4138/DELNP/2012  Application date in the designated or member state=2012-05-10   Application number in the designated or member state=2012IN-DN04138 Corresponding cc:  Designated or member state=IN Corresponding pat: IN4138/DELNP/2012  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2015-11-06   Publication number in the designated or member state=IN2012DN04138 LEGAL DETAILS FOR DESIGNATED STATE JP2013515084  Actual or expected expiration date=2030-12-22    Legal state=ALIVE    Status=PENDING   Corresponding cc:  Designated or member state=JP Corresponding appl: JP2012546191  Application date in the designated or member state=2010-12-22   Application number in the designated or member state=2012JP-0546191 Corresponding cc:  Designated or member state=JP Corresponding pat: JP2013515084  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2013-05-02   Publication number in the designated or member state=JP2013515084    Event publication date=2012-06-21  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=JP  LEGAL DETAILS FOR DESIGNATED STATE KR20120104390  Actual or expected expiration date=2016-01-23    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=KR Corresponding appl: KR20127019176  Application date in the designated or member state=2010-12-22   Application number in the designated or member state=2012KR-7019176 Corresponding cc:  Designated or member state=KR Corresponding pat: KR20120104390  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2012-09-20   Publication number in the designated or member state=KR20120104390    Event publication date=2012-07-20  Event code=WO/ENP  Event type=Entry into national phase  Entry into the national phase in: Corresponding cc:  Designated or member state=KR     Event publication date=2016-01-23  Event code=KR/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=KR  LEGAL DETAILS FOR DESIGNATED STATE MX2012007223  Actual or expected expiration date=2030-12-22    Legal state=ALIVE    Status=PENDING   Corresponding cc:  Designated or member state=MX Corresponding appl: MX2012007223  Application date in the designated or member state=2010-12-22   Application number in the designated or member state=2012MX-PA07223 Corresponding cc:  Designated or member state=MX Corresponding pat: MX2012007223  Publication stage code in the designated or member state=A  Publication date in the designated or member state=2012-07-17   Publication number in the designated or member state=MX2012007223 LEGAL DETAILS FOR DESIGNATED STATE US2012283216  Actual or expected expiration date=2013-08-08    Legal state=DEAD    Status=LAPSED   Corresponding cc:  Designated or member state=US Corresponding appl: US13513056  Application date in the designated or member state=2010-12-22   Application number in the designated or member state=2010US-13513056 Corresponding cc:  Designated or member state=US Corresponding pat: US2012283216  Publication stage code in the designated or member state=A1  Publication date in the designated or member state=2012-11-08   Publication number in the designated or member state=US20120283216    Event publication date=2012-05-31  Event code=WO/WWE  Event indicator=Pos  Event type=Entry into national phase  Wipo information: entry into national phase Corresponding cc:  Designated or member state=US     Event publication date=2013-08-08  Event code=US/STCHG  Patent Status changed by the national office Corresponding cc:  Designated or member state=US
专利类型码
A2A9A3
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部